Fulcrum Therapeutics Inc.
FULC | NASDAQ
$3.80
+$0.04 (+1.06%)
At close: Sep 21, 2026, 4:00 PM ET
$3.80
$0 (0.00%)
Pre-market:
Sep 22, 2026, 8:32 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 80M | n/a | 871K | 759K | 880K | 295K | 685K | 1.18M | 1.88M | 2.59M | 5.06M | 4.94M | 4.38M | 4.79M |
Cost of Revenue | n/a | 338K | -300K | 14.3M | 300K | 13.4M | 369K | 14.64M | 17.26M | 479K | 508K | 18.24M | 17.85M | 16.72M | 18.57M | 15.37M | 25.02M | 17.83M | 18.91M | 17.08M | 17.38M | 16.33M |
Gross Profit | n/a | -338K | 300K | -14.3M | -300K | -13.4M | -369K | -14.64M | 62.74M | -479K | 363K | -17.48M | -16.97M | -16.42M | -17.88M | -14.18M | -23.14M | -15.24M | -13.85M | -12.14M | -13M | -11.55M |
Operating Income | -29.31M | -22.19M | -22.69M | -21.86M | -19.82M | -20.4M | -19.43M | -25.13M | 52.49M | -29.83M | -27.99M | -27.44M | -27.29M | -27.94M | -27.97M | -24.36M | -34.24M | -26M | -23.56M | -20.77M | -19.68M | -17.04M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -26.18M | -18.89M | -20.33M | -19.6M | -17.3M | -17.66M | -16.57M | -21.7M | 55.41M | -26.87M | -24.76M | -24.02M | -23.78M | -24.78M | -26.14M | -23.74M | -34.07M | -25.93M | -23.48M | -20.72M | -19.65M | -17M |
Net Income | -26.18M | -18.89M | -20.33M | -19.6M | -17.3M | -17.66M | -16.57M | -21.7M | 55.41M | -26.87M | -24.76M | -24.02M | -23.78M | -24.78M | -26.14M | -23.74M | -34.07M | -25.93M | -23.48M | -20.72M | -19.65M | -17M |
Selling & General & Admin | 7.46M | 8.1M | 7.28M | 7.56M | 6.83M | 7M | 7.72M | 8.42M | 10.25M | 10.06M | 9.36M | 9.96M | 10.32M | 11.52M | 10.13M | 9.71M | 11.1M | 10.76M | 9.71M | 8.63M | 6.69M | 5.5M |
Research & Development | 12.44M | 14.08M | 15.42M | 14.3M | 12.99M | 13.4M | 11.34M | 14.64M | 17.26M | 19.29M | 19M | 18.24M | 17.85M | 16.72M | 18.57M | 15.37M | 25.02M | 17.83M | 18.91M | 17.08M | 17.38M | 16.33M |
Other Expenses | 9.4M | -338K | 300K | -14.3M | -300K | -13.4M | n/a | -12.58M | -17.26M | n/a | n/a | -18.24M | -17.85M | -16.72M | -18.6M | -14.9M | -25.02M | -17.83M | -18.91M | -17.08M | -17.38M | -16.33M |
Operating Expenses | 29.31M | 21.85M | 22.99M | 7.56M | 19.52M | 7M | 19.06M | 10.49M | 10.25M | 29.36M | 28.36M | 9.96M | 10.32M | 11.52M | 10.09M | 10.17M | 11.1M | 10.76M | 9.71M | 8.63M | 6.69M | 5.5M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 260K | n/a | 308K | n/a | 285K | 271K | n/a | -508K | 640K | 616K | 657K | -569K | 569K | 526K | 441K | -623K | 224K | 191K | 208K |
Cost & Expenses | n/a | 22.19M | 22.69M | 21.86M | 19.82M | 20.4M | 19.43M | 25.13M | 27.51M | 29.83M | 28.86M | 28.2M | 28.17M | 28.24M | 28.66M | 25.54M | 36.12M | 28.59M | 28.62M | 25.71M | 24.06M | 21.83M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 76.26M | 76.22M | 63.36M | 62.6M | 62.54M | 62.48M | 53.95M | 62.41M | 62.21M | 61.98M | 61.87M | 61.82M | 61.79M | 59.72M | 52.08M | 46.21M | 40.89M | 40.64M | 40.58M | 36.61M | 32.64M | 31.51M |
Shares Outstanding (Diluted) | 76.26M | 76.22M | 63.36M | 62.6M | 62.54M | 62.48M | 53.95M | 62.41M | 63.59M | 61.98M | 61.87M | 61.82M | 61.79M | 59.72M | 52.08M | 46.21M | 40.89M | 40.64M | 40.58M | 36.61M | 32.64M | 31.51M |
EPS (Basic) | -0.34 | -0.25 | -0.31 | -0.31 | -0.28 | -0.28 | -0.31 | -0.35 | 0.89 | -0.43 | -0.40 | -0.39 | -0.38 | -0.36 | -0.45 | -0.52 | -0.83 | -0.64 | -0.58 | -0.57 | -0.60 | -0.54 |
EPS (Diluted) | -0.34 | -0.25 | -0.31 | -0.31 | -0.28 | -0.28 | -0.31 | -0.35 | 0.87 | -0.43 | -0.40 | -0.39 | -0.38 | -0.36 | -0.45 | -0.52 | -0.83 | -0.64 | -0.58 | -0.57 | -0.60 | -0.54 |
EBITDA | -29.31M | -18.55M | -19.99M | -19.25M | -16.95M | -17.3M | -16.2M | -22.69M | 55.79M | -26.39M | -24.25M | -23.49M | -23.22M | -24.21M | -27.42M | -23.28M | -33.39M | -25.39M | -22.86M | -20.1M | -18.98M | -16.44M |
EBIT | n/a | -18.89M | -20.33M | -19.6M | -17.3M | -17.66M | -16.57M | -23.06M | 55.41M | -26.87M | -24.76M | -24.02M | -23.78M | -24.78M | -28.01M | -23.89M | -34.07M | -25.93M | -23.48M | -20.72M | -19.65M | -17.04M |
Depreciation & Amortization | n/a | 338K | 347K | 346K | 344K | 353K | 369K | 369K | 376K | 479K | 508K | 531K | 567K | 566K | 591K | 611K | 676K | 536K | 621K | 619K | 672K | 603K |
Add to Watchlist
Select watchlists to add or remove FULC